{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "However, there is a lack of randomized controlled trials evaluating the effectiveness, safety, cost-effectiveness, and user demand for internet-based anticoagulation management."
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This study was a randomized controlled trial with assessments conducted at baseline and at a 3-month follow-up."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were eligible if they had been on warfarin therapy for at least 3 months, received warfarin management either through the Alfalfa app or through pharmacist-led anticoagulation outpatient clinic visits, consented to regular follow-ups, and had not experienced serious bleeding or thrombotic events in the 3 months before warfarin treatment."
      },
      "Intervention": {
        "score": 2,
        "evidence": "This study aimed to evaluate the efficacy, safety, and cost-effectiveness of a 3-month warfarin dose adjustment mobile app Alfalfa compared to offline management in patients postcardiac valve replacement."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: This study aimed to evaluate the efficacy, safety, and cost-effectiveness of a 3-month warfarin dose adjustment mobile app Alfalfa compared to offline management in patients postcardiac valve replacement."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "This study was a randomized controlled trial with assessments conducted at baseline and at a 3-month follow-up."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 405 participants were included in the analysis."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 405 participants were included in the analysis."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The time in therapeutic range was significantly higher in the Alfalfa app group than in the offline group (66.46% vs 46.65%, P <.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "However, the incidence of minor bleeding was higher in the Alfalfa app group (12/204, 5.9% vs 3/201, 1.5%; P =.02)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}